ClinicalTrials.govpublic full text
The Efficacy and Safety of Paclitaxel Monotherapy Versus Paclitaxel-Carboplatin Combination as Neoadjuvant Chemotherapy in Advanced Ovarian Cancer With High PARK2 Expression
ovarian cancer, neoadjuvant chemotherapy, paclitaxel, carboplatin, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 830061
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.